Elevation Wealth Partners’s Biogen BIIB Stock Holding History

Elevation Wealth Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$48.2K	Buy	223 +19	+9%	+$3.63K	0.01%	311
2026 Q1	$37.4K	Buy	204 +4	+2%	+$737	0.01%	282
2025 Q4	$35.2K	Buy	200 +161	+413%	+$26.3K	0.01%	284
2025 Q3	$5.46K	Buy	39 +9	+30%	+$1.22K	﹤0.01%	464
2025 Q2	$3.77K	Hold	30	–	–	﹤0.01%	417
2025 Q1	$4.11K	Hold	30	–	–	﹤0.01%	420
2024 Q4	$4.59K	Sell	30 -28	-48%	-$4.72K	﹤0.01%	414
2024 Q3	$11.2K	Hold	58	–	–	﹤0.01%	349
2024 Q2	$13.4K	Hold	58	–	–	0.01%	323
2024 Q1	$12.5K	Buy	58 +28	+93%	+$6.56K	0.01%	338
2023 Q4	$7.71K	Hold	30	–	–	﹤0.01%	350
2023 Q3	$7.71K	Hold	30	–	–	0.01%	256
2023 Q2	$8.55K	Hold	30	–	–	0.01%	262
2023 Q1	$8.34K	Buy	+30	New	+$8.3K	0.01%	269

Other funds holding BIIB

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ADEF

Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Elevation Wealth Partners's BIIB Position: Q2 2026 in Review

Elevation Wealth Partners increased its Biogen (BIIB) stake by 9.3% in Q2 2026, buying an estimated $3.63K and bringing the position to 223 shares worth $48.2K. The position accounts for 0.01% of the portfolio, ranked #311.

Elevation Wealth Partners first reported a position in BIIB in Q1 2023 and has held it in 14 quarters since. 380 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Elevation Wealth Partners held 223 shares of Biogen worth $48.2K as of Q2 2026.
Elevation Wealth Partners bought 19 Biogen shares in Q2 2026, an estimated $3.63K.
Biogen made up 0.01% of Elevation Wealth Partners's portfolio in Q2 2026, its #311 holding.
Elevation Wealth Partners first reported a position in Biogen in Q1 2023 and has held it in 14 quarters since.
380 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.